Navigation Links
Amylin Pharmaceuticals Reports 2010 Financial Results
Date:1/26/2011

ll focus on our highest corporate priority – responding to the recent complete response letter for BYDUREON – so that we can make this important therapy available to patients in the U.S. as soon as possible. While we advance this and other value drivers, we will continue to aggressively manage expenses to position Amylin for sustainable growth in the years ahead."

Fourth Quarter Highlights Highlights of Amylin's fourth quarter and recent activities include:

BYDUREON

  • Received written feedback from the U.S. Food and Drug Administration (FDA) indicating approval of the study design for the required thorough QT (tQT) study to support the regulatory application for BYDUREON™ (exenatide extended-release for injectable suspension).  The study is expected to begin in February.

  • BYETTA

  • Received $10 million milestone payment upon launch of BYETTA® (exenatide) injection by partner Eli Lilly and Company in Japan for the treatment of type 2 diabetes in patients who have not achieved adequate glycemic control while taking certain oral anti-diabetes therapies in addition to diet and exercise.
  • Announced results from a retrospective study of nearly 375,000 type 2 diabetes patients evaluating the incidence of events related to cardiovascular disease (CVD) and all-cause hospitalizations among initiators of BYETTA compared to initiators of other commonly used diabetes medications. In the study, BYETTA was associated with a lower incidence of CVD-related events than insulin, thiazolidinediones (TZDs) and sulfonylureas and a comparable incidence versus metformin and Januvia® (sitagliptin). BYETTA was also associated with a lower incidence of all-cause hospitalizations than insulin, TZDs and sulfonylureas; a comparable incidence versus metformin and a higher incidence than Januvia.
  • Submitted a supplemental New Drug Application (sNDA) to the FDA for the expanded use of BYETTA as an ad
    '/>"/>

  • SOURCE Amylin Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Amylin Pharmaceuticals to Webcast Year-End Financial Results
    2. Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
    3. Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
    4. Amylin Pharmaceuticals Reports Third Quarter Financial Results
    5. Amylin Pharmaceuticals to Present at the 2010 Credit Suisse Healthcare Conference
    6. Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™
    7. Amylin Pharmaceuticals to Webcast Third Quarter Results
    8. Amylin Pharmaceuticals to Present at the Wedbush Life Sciences Conference 2010
    9. Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development
    10. Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference
    11. Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/3/2015)... DALLAS , June 3, 2015 ... report "Interventional Cardiology & Peripheral Vascular Devices Market ... Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, ... by MarketsandMarkets, the Interventional Cardiology and Peripheral Vascular ... Billion by 2019 with a CAGR of 7.4% ...
    (Date:6/3/2015)... June 3, 2015  SurgiQuest®, Inc. ("SurgiQuest", the ... for minimally invasive surgery (MIS) announced today that ... over 250,000 procedures.  Adoption has risen rapidly with ... year, driven by the company,s expansion from robotics ... geographic expansion to over 45 countries.   ...
    (Date:6/3/2015)... , June 3, 2015 PillPack, the ... completed a $50 million round of financing led by ... Ventures, and Sherpa Ventures. The capital will be used ... team, and build retail pharmacies in US markets. ... launched a better, simpler pharmacy experience that folks absolutely ...
    Breaking Medicine Technology:The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 2The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 3The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 4Rapid Procedure Growth With SurgiQuest's AirSeal System 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 3
    ... The U.S. Food and Drug Administration is warning consumers again ... King International and sold by various companies, due to serious ... Shoulder Flex Massager is a personal massage device sold ... intended to provide users with a deep tissue massage to ...
    ... Pharmaceuticals, Inc. (Nasdaq: AMPE)("Ampio" or the "Company"), a company ... drugs and new molecular entities ("NMEs"), announced today that ... to sell an aggregate approximately 2,220,255 of shares of ... "Shares"), at a price per share of $4.25 in ...
    Cached Medicine Technology:FDA: Do Not Use ShoulderFlex Massagers 2FDA: Do Not Use ShoulderFlex Massagers 3Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million 2Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million 3
    (Date:6/3/2015)... (PRWEB) June 03, 2015 Visual ... Analytics solutions, today announced the launch of the ... (DSX) for SAP® BusinessObjects™ Design Studio. The Design ... visualization capabilities and advanced functionalities into their dashboarding ... DSX suite, Visual BI is adding key components ...
    (Date:6/3/2015)... 2015 For the fourth time in less ... a full-service advertising agency, has been honored by a respected ... , MCA has been selected as a Semi-Finalist for the ... be honored at a luncheon sponsored by Adcock Financial Group ... of Art. , “This luncheon will include important information about ...
    (Date:6/3/2015)... June 03, 2015 On Sunday, June ... world will gather in their local communities to observe ... cities across the U.S. and abroad will hold celebrations ... attention to the ongoing challenges of cancer survivorship, and ... diagnosis can be fruitful, rewarding, and inspiring.,  , National ...
    (Date:6/3/2015)... June 03, 2015 Implant design can ... osseointegration processes that unites bone to an implant surface. ... has been designed to encourage bone regeneration, resulting in ... of stable surrounding soft tissues for more esthetic restorations. ... Product Manager at MIS Implants. The triangular neck of ...
    (Date:6/3/2015)... First Choice Emergency Room , ... the United States, announced that it is opening its ... , “I am pleased to announce that we ... facility in the San Antonio area,” said Dr. James ... Room. , First Choice Emergency Room is revolutionizing ...
    Breaking Medicine News(10 mins):Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 2Health News:My Classified Ads Has Been Selected as a Semi-Finalist for the 2015 ‘Small Business of the Year’ Awards 3Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 2Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 3Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 4Health News:MIS Implants Launches Radically New V3 Dental Implant For Immediate Biological Benefits 2Health News:First Choice Emergency Room to Open New Facility in San Antonio, Texas 2
    ... annually may improve life expectancy, study finds , ... both mammography and MRI appears to be a cost-effective ... risk for breast cancer, U.S. researchers say. , In ... Massachusetts General Hospital in Boston, and colleagues used statistical ...
    ... Can,t predict which patients are at risk for excessive bleeding ... -- Tests that try to single out who will have ... Plavix before surgery aren,t ready for regular use, a new ... measure the function of platelets, the blood cells that clump ...
    ... , ... ... , ... , , ...
    ... ... includes iCardio™, iRunner™, iBiker™, iSpinner™ and iPower™ - all together nowSM and available ... ... ANT Wireless, a division of Dynastream Innovations Inc. and iTMP Technology, a leader ...
    ... ... ... , ... , , , , ...
    ... a common dietary supplement, exerts a significant effect against ... chemopreventive agent against this form of cancer, according to ... findings suggest that bitter melon extract modulates several signal ... lead researcher Ratna B. Ray, Ph.D., professor in the ...
    Cached Medicine News:Health News:Mammogram Plus MRI Cost-Effective in High-Risk Women 2Health News:Tests to Measure Safety of Anti-Clotting Drugs of Limited Value 2Health News:Tests to Measure Safety of Anti-Clotting Drugs of Limited Value 3Health News:Bread for the World, USDA Secretary Urge Congress to End Child Hunger in U.S. 2Health News:Bread for the World, USDA Secretary Urge Congress to End Child Hunger in U.S. 3Health News:ANT+ and iTMP Announce the Digifit™ Ecosystem - The First iPhone™ Apps to Integrate Running, Cycling and Heart Rate Monitoring 2Health News:ANT+ and iTMP Announce the Digifit™ Ecosystem - The First iPhone™ Apps to Integrate Running, Cycling and Heart Rate Monitoring 3Health News:Johnson & Johnson to Participate in RBC Capital Markets' Health Care Conference 2Health News:Bitter melon extract decreased breast cancer cell growth 2
    ... The Smith & Nephew ECTRA II ... release the carpal tunnel ligament endoscopically, allowing ... proximal cutting, while minimizing endoscopic lens fogging ... the surgeon complete visualization and control. ECTRA ...
    Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
    Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
    ... Cross-Screw System offers the surgeon ... for ACL reconstruction utilizing soft ... System provides the latest technology ... comes in Titanium as well ...
    Medicine Products: